Equifax SEC filings document the company’s operating results, capital structure, governance, and material corporate agreements. Recent Form 8-K reports include quarterly financial-results releases and amendments to the company’s unsecured revolving credit facility involving Equifax and subsidiary borrowers.
Regulatory records also identify Equifax common stock listed on the New York Stock Exchange under EFX. Proxy materials cover annual meeting matters, board and shareholder voting topics, executive compensation, and company discussion of data, cloud technology, security, and EFX.AI within its public-company governance framework.
Equifax Inc. (EFX) shares were reported as beneficially owned by Capital International Investors: 7,382,912 shares, or 6.3% of the class. Capital International Investors reported sole voting power over 7,342,796 shares and sole dispositive power over all 7,382,912 shares; shared voting and dispositive power were both zero.
Equifax Inc. (EFX) EVP, Chief Technology Officer Jamil Farshchi sold 15,110 common shares at $189.77 per share on November 9, 2026. The sale was made under a Rule 10b5-1 trading plan adopted August 11, 2026.
Equifax Inc. officer Jamil Farshchi reported 15,110 common shares for sale, with an approximate sale date of November 9, 2026; the stated aggregate market value is $2,867,424.70. The notice lists August 11, 2026, as the date of plan adoption or instruction, if relying on Rule 10b5-1. The shares listed were acquired from the issuer through restricted stock vesting in four tranches: 7,656 shares on February 22, 2022; 2,672 shares on February 21, 2023; 2,595 shares on February 12, 2024; and 2,187 shares on February 11, 2025.
Equifax Inc. (EFX) EVP, CFO & COO John W. Gamble Jr. sold 4,000 shares of common stock on October 29, 2026, at $177.68 per share. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Gamble on May 28, 2026. After the sale, he directly held 65,145 shares; that amount includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the company’s last dividend payment date.
Equifax Inc. EVP, Chief D&A Officer Harald Schneider had 689 shares delivered or withheld for payment of exercise price or tax liability on October 30, 2026. The reported per-share price was $184.60. His direct position following the transaction was 8,589 shares, including accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the company’s last dividend payment date. No Rule 10b5-1 plan is reported.
Equifax Inc. (EFX) lists officer John W. Gamble Jr. as proposing to sell 4,000 common shares through Fidelity Brokerage Services LLC, with an aggregate market value of $710,720.00 and an approximate sale date of October 29, 2026. The notice also reports a prior sale of 4,500 common shares on September 3, 2026, for gross proceeds of $845,820.00.
Equifax Inc. CEO Mark W. Begor exercised options covering 37,792 shares of common stock on October 23, 2026, at an exercise price of $112.46 per share, then sold 37,792 shares that day in four transactions. The reported option position was zero after the exercise. The sales were made under a Rule 10b5-1 trading plan adopted October 28, 2025.
Reported sale prices were 1,194 shares at a weighted average of $186.7335 per share; 1,250 at $183.4030; 1,681 at a weighted average of $185.2034; and 33,667 at a weighted average of $182.5170. Separate indirect common-stock holdings were listed in five GRATs: 2,350 shares in the 2-yr Apr 2025 GRAT, 21,284 in the 2-yr Dec 2025 GRAT, 20,512 in the 2-yr Jun 2025 GRAT, 2,018 in the 2-yr May 2025 GRAT, and 18,562 in the 2-yr May 2026 GRAT.
Equifax Inc. officer Cecilia Mao reported a proposed sale of 8,290 common shares, with an aggregate market value of $1,513,117.28. The approximate sale date is October 23, 2026, and Fidelity Brokerage Services LLC is listed in connection with the shares.
The listed share history includes restricted stock vesting entries and a 2,400-share open-market purchase dated February 18, 2026.
Equifax Inc. common shares are included in a planned sale for officer and director Mark W. Begor’s account: 37,792 shares, with an aggregate market value of $6,908,341.33. Fidelity Brokerage Services LLC is listed as broker, with October 23, 2026, as the approximate sale date and NYSE as the exchange. An associated acquisition entry describes a stock-option exercise involving 37,792 shares, dated October 23, 2026, with cash as the payment method. A separate sale of 37,791 shares on July 24, 2026, is reported at an aggregate market value of $6,506,253.50.
Equifax Inc. (EFX) reported third-quarter operating revenue of $1,692.5 million, up 10% from $1,544.9 million a year earlier. Net income attributable to Equifax was $211.7 million, versus $160.2 million, and diluted earnings per share were $1.79, versus $1.29. Operating income was $355.3 million, compared with $264.3 million, and operating margin was 21.0%, versus 17.1%. Revenue grew in each segment: Workforce Solutions 7%, U.S. Information Solutions 13%, and International 9%.
For the first nine months, revenue was $5,041.5 million, up 11%; net income attributable to Equifax was $567.1 million, versus $484.5 million, and diluted EPS was $4.75, versus $3.89. Cash provided by operating activities was $1,142.1 million, compared with $1,144.9 million. Equifax repurchased 3,640,019 shares on the open market for $652.0 million, excluding $5.8 million in brokerage commissions and excise taxes; approximately $1.4 billion remained available at September 30, 2026. The board increased the quarterly dividend to $0.56 per share beginning in the first quarter of 2026.